CYTOKINETICS INCORPORATED - COMMON STOCK
41.49
12-February-25 10:55:40
15 minutes delayed
Stocks
-0.07
-0.17%
Today's range
40.53 - 42.25
ISIN
N/A
Source
NASDAQ
-
08 May 2024 06:30:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Topline Data From Phase 1 Clinical Study of CK-4021586
08 May 2024 06:30:00 By Nasdaq GlobeNewswire
-
Cytokinetics to Hold Annual Meeting of Stockholders
07 May 2024 15:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 May 2024 15:00:00 By Nasdaq GlobeNewswire
-
29 Apr 2024 15:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics to Announce First Quarter Results on May 8, 2024
24 Apr 2024 15:00:00 By Nasdaq GlobeNewswire
-
10 Apr 2024 06:30:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 Apr 2024 15:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
01 Apr 2024 15:00:00 By Nasdaq GlobeNewswire
-
25 Mar 2024 07:15:04 By Nasdaq GlobeNewswire
-
Cytokinetics to Participate in March Investor Conferences
04 Mar 2024 15:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Mar 2024 15:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day
29 Feb 2024 06:30:00 By Nasdaq GlobeNewswire
-
28 Feb 2024 06:30:00 By Nasdaq GlobeNewswire
-
Cytokinetics Reports Fourth Quarter 2023 Financial Results
27 Feb 2024 15:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics to Announce Fourth Quarter Results on February 27, 2024
13 Feb 2024 15:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
06 Feb 2024 15:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Recipients of Its Sixth Annual Communications Grant Program
29 Jan 2024 06:30:00 By Nasdaq GlobeNewswire